Alcon Cut to Sell as Underperformance, Competitive Pressure and Softer Markets Drive Price Target Reduction from CHF50 to CHF48
at www.tipranks.com (Tue, 21-Jul 12:11 PM)
Analysts Conflicted on These Healthcare Names: Alcon (ALC), Palvella Therapeutics (PVLA) and Cardinal Health (CAH)
at www.tipranks.com (Tue, 21-Jul 12:02 PM)
Alcon Boosts Core Earnings and Announces $1.5 Billion Share Buyback as New Products Fuel First-Quarter Growth
Market Chameleon (Wed, 6-May 7:12 AM)
